Hematologist-Oncologist: Sucha Nand, MD | Loyola Medicine

Sucha Nand, MD

Sucha Nand, MD



Languages Spoken

English, Hindi,Punjabi
Patient Ratings
5 / 5 (134 Ratings)

Clinical Expertise

  • Amyloidosis
  • Bone Marrow Disorders
  • Cancer Of The Blood And Blood Cells
  • Clotting Disorders
  • Diagnosis Of Bleeding Or Clotting Disorders
  • Hodgkin's Lymphoma
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma

About Dr. Nand

Reading, Running, Chess

Medical Education

Medical School
Amritsar Medical College/Punjab University, India
Amritsar Medical College Hospital
India - Internal Medicine: General
Sir HN Hospital
India - Internal Medicine: General
VA Medical Center
North Chicago/Chicago Medical School - Internal Medicine: General
  • Northwestern University McGaw Medical Center - Internal Medicine: Hematology & Medical Oncology

Board Certification

American Board of Internal Medicine Subspecialty Hematology
American Board of Internal Medicine Subspecialty Medical Oncology
American Board of Internal Medicine, Medical Oncology


  • Myeloproliferative Neoplasms Nand, S., The New England journal of medicine
  • Neurological Complications of the Leukemias Across the Ages Berg, S.; Nand, S., Current neurology and neuroscience reports
  • Sensitizing leukemia stem cells to NF-kappaB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling Li, J.; Volk, A.; Zhang, J.; Cannova, J.; Dai, S.; Hao, C.; Hu, C.; Sun, J.; Xu, Y.; Wei, W.; Breslin, P.; Nand, S.; Chen, J.; Kini, A.; Zhu, J.; Zhang, J., Oncotarget
View All ResearchShow Less
  • Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients Achille, N. J.; Othus, M.; Phelan, K.; Zhang, S.; Cooper, K.; Godwin, J. E.; Appelbaum, F. R.; Radich, J. P.; Erba, H. P.; Nand, S.; Zeleznik-Le, N. J., Leukemia research
  • Relationhip between event-free survival and overall survival in acute myeloid leukemia: A report from SWOG HOVN/SAKK, and MRC/NCRI, Othus, M.; van Putten, W.; Lowenberg, B.; Petersdorf, S. H.; Nand, S.; Erba, H.; Appelbaum, F.; Hills, R.; Russell, N.; Burnett, A.; Estey, E., Haematologica
  • Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway Xin, J.; You, D.; Breslin, P.; Li, J.; Zhang, J.; Wei, W.; Cannova, J.; Volk, A.; Gutierrez, R.; Xiao, Y.; Ni, A.; Ng, G.; Schmidt, R.; Xia, Z.; Pan, J.; Chen, H.; Patel, M. M.; Kuo, P. C.; Nand, S.; Kini, A. R.; Zhang, J.; Chen, J.; Zhu, J.; Zhang, J., Leukemia
  • Anaplastic large cell lymphoma involving the urinary bladder: a case report and review of the literature Chen, H.; Li, Y.; Nand, S.; Quek, M. L.; Kini, A. R.; Barkan, G. A., Diagnostic cytopathology
  • FAK Mediates a Compensatory Survival Signal Parallel to PI3K-AKT in PTEN-Null T-ALL Cells You, D.; Xin, J.; Volk, A.; Wei, W.; Schmidt, R.; Scurti, G.; Nand, S.; Breuer, E. K.; Kuo, P. C.; Breslin, P.; Kini, A. R.; Nishimura, M. I.; Zeleznik-Le, N. J.; Zhang, J., Cell reports
  • Anemias excluding cobalamin and folate deficiencies Dublis, S.; Shah, S.; Nand, S.; Anderes, E., Handbook of clinical neurology
  • Co-inhibition of NF-kappaB and JNK is synergistic in TNF-expressing human AML Volk, A.; Li, J.; Xin, J.; You, D.; Zhang, J.; Liu, X.; Xiao, Y.; Breslin, P.; Li, Z.; Wei, W.; Schmidt, R.; Li, X.; Zhang, Z.; Kuo, P. C.; Nand, S.; Zhang, J.; Chen, J.; Zhang, J., The Journal of experimental medicine
  • Commonly used drugs in hematologic disorders Anderes, E.; Nand, S., Handbook of clinical neurology
  • Heckathorn disease revisited Nand, S.; Barton, K.; Schultz, R.; Klein, M.; Kini, A., Blood
  • A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia Nand, S.; Othus, M.; Godwin, J. E.; Willman, C. L.; Norwood, T. H.; Howard, D. S.; Coutre, S. E.; Erba, H. P.; Appelbaum, F. R., Blood
  • Cerebral Vein and Dural Venous Sinus Thrombosis: Risk Factors Prognosis and Treatment—a Modern Approach, Paner, A.; Jay, W. M.; Nand, S.; Michaelis, L. C., Neuro-Ophthalmology
  • Hydroxyurea azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial, Nand, S.; Godwin, J.; Smith, S.; Barton, K.; Michaelis, L.; Alkan, S.; Veerappan, R.; Rychlik, K.; Germano, E.; Stiff, P., Leukemia & lymphoma
  • Inherited thrombophilia and the eye Czerlanis, C.; Jay, W. M.; Nand, S., Seminars in ophthalmology
  • Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder Portell, C.; Nand, S., Blood
  • Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge Nand, S.; Barton, K., Leukemia & lymphoma
  • A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. Naeem, M.; Harrison, K.; Barton, K.; Nand, S.; Alkan, S., European journal of haematology
  • Thromboembolism in cancer patients: pathogenesis and treatment Adess, M.; Eisner, R.; Nand, S.; Godwin, J.; Messmore, H. L., Jr; Wehrmacher, W. H., Clinical & Applied Thrombosis/Hemostasis
  • Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. Alkan, S.; Huang, Q.; Ergin, M.; Denning, M. F.; Nand, S.; Maududi, T.; Paner, G. P.; Ozpuyan, F.; Izban, K. F., American Journal of Hematology
  • A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies Hesketh, P. J.; Arena, F.; Patel, D.; Austin, M.; D'Avirro, P.; Rossi, G.; Colowick, A.; Schwartzberg, L.; Bertoli, L. F.; Cole, J. T.; Demetri, G.; Dessypris, E.; Dobbs, T.; Eisenberg, P.; Fleischman, R.; Hall, J.; Hoffman, P. C.; Laber, D. A.; Leonard, J.; Lester, E. P.; McCachren, S.; McMeekin, S.; Meza, L.; Miller, D. S.; Nand, S.; Oliff, I.; Paroly, W.; Pawl, L.; Perez, A.; Raftopoulos, H.; Rigas, J.; Rowland, K.; Scullin, D. C., Jr; Tezcan, H.; Waples, J.; Ward, J.; Yee, L. K., Cancer
  • Herpes zoster during treatment with arsenic trioxide Tanvetyanon, T.; Nand, S., Annals of Hematology
  • Lymphoproliferative disorders in chronic hepatitis C. Idilman, R.; Colantoni, A.; De Maria, N.; Alkan, S.; Nand, S.; Van Thiel, D. H., Journal of viral hepatitis
  • Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Houde, C.; Li, Y.; Song, L.; Barton, K.; Zhang, Q.; Godwin, J.; Nand, S.; Toor, A.; Alkan, S.; Smadja, N. V.; Avet-Loiseau, H.; Lima, C. S.; Miele, L.; Coignet, L. J., Blood
  • Pancytopenia in hereditary haemorrhagic telangiectasia. Tanvetyanon, T.; Nand, S., British journal of haematology
  • Hairy cell leukemia variant developing in a background of polycythemia vera Kelly, N. P.; Alkan, S.; Nand, S., Archives of Pathology & Laboratory Medicine
  • Overcoming recurrent cutaneous reactions from imatinib using once-weekly dosing. Tanvetyanon, T.; Nand, S., Annals of Pharmacotherapy
  • Hepatitis C virus infection and lymphoproliferative disorders Pena, L. R.; Nand, S.; De Maria, N.; Van Thiel, D. H., Digestive diseases and sciences